Ursolic acid inhibits the invasive phenotype of SNU-484 human gastric cancer cells

Kim,Eun‑Sook; Moon,Aree

doi:10.3892/ol.2014.2735

Ursolic acid inhibits the invasive phenotype of SNU-484 human gastric cancer cells

Authors:
- Eun‑Sook Kim
- Aree Moon
View Affiliations

Affiliations: College of Pharmacy, Innovative Drug Center, Duksung Women's University, Seoul 132‑714, Republic of Korea
Published online on: November 24, 2014 https://doi.org/10.3892/ol.2014.2735
Pages: 897-902

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metastasis is a major cause of cancer‑related mortality in patients with gastric cancer. Ursolic acid, a pentacyclic triterpenoid compound derived from medicinal herbs, has been demonstrated to exert anticancer effects in various cancer cell systems. However, to the best of our knowledge, the inhibitory effect of ursolic acid on the invasive phenotype of gastric cancer cells has yet to be reported. Therefore, the aim of the present study was to investigate the effect of ursolic acid on the invasiveness of SNU‑484 human gastric cancer cells. Ursolic acid efficiently induced apoptosis, possibly via the downregulation of B‑cell lymphoma 2 (Bcl‑2), the upregulation of Bcl‑2‑associated X protein and the proteolytic activation of caspase‑3. Furthermore, the activation of p38 mitogen‑activated protein kinase and c‑Jun N‑terminal kinase was increased by the administration of ursolic acid. In addition, ursolic acid significantly suppressed the invasive phenotype of the SNU‑484 cells and significantly decreased the expression of matrix metalloproteinase (MMP)‑2, indicating that MMP‑2 may be responsible for the anti‑invasive activity of ursolic acid. Taken together, the results of the present study demonstrate that ursolic acid induces apoptosis and inhibits the invasive phenotype of gastric cancer cells; therefore, ursolic acid may have a potential application as a chemopreventive agent to prevent the metastasis of gastric cancer or to alleviate the process of metastasis.

View Figures

View References

1	Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in gastric cancer: a global overview. Int J Cancer. 125:666–673. 2009. View Article : Google Scholar : PubMed/NCBI
2	Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, et al; Asia Pacific Working Group of Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
3	Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol. 12:354–362. 2006.PubMed/NCBI
4	Macdonald JS: Gastric cancer - new therapeutic options. N Engl J Med. 355:76–77. 2006. View Article : Google Scholar : PubMed/NCBI
5	Cunningham D and Chua YJ: East meets west in the treatment of gastric cancer. N Engl J Med. 357:1863–1865. 2007. View Article : Google Scholar : PubMed/NCBI
6	Ngo SN, Williams DB and Head RJ: Rosemary and cancer prevention: preclinical perspectives. Crit Rev Food Sci Nutr. 51:946–954. 2011. View Article : Google Scholar : PubMed/NCBI
7	Shishodia S, Majumdar S, Banerjee S and Aggarwal BB: Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63:4375–4383. 2003.PubMed/NCBI
8	Wang X, Zhang F, Yang L, Mei Y, Long H, Zhang X, Zhang J, Qimuge-Suyila and Su X: Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol. 2011:4193432011. View Article : Google Scholar : PubMed/NCBI
9	Lin CC, Huang CY, Mong MC, Chan CY and Yin MC: Antiangiogenic potential of three triterpenic acids in human liver cancer cells. J Agric Food Chem. 59:755–762. 2011. View Article : Google Scholar
10	Huang CY, Lin CY, Tsai CW and Yin MC: Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. Toxicol In Vitro. 25:1274–1280. 2011. View Article : Google Scholar : PubMed/NCBI
11	Li Y, Xing D, Chen Q and Chen WR: Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-κB using ursolic acid. Int J Cancer. 127:462–473. 2010.
12	Ma CM, Cai SQ, Cui JR, Wang RQ, Tu PF, Hattori M, Hattori M and Daneshtalab M: The cytotoxic activity of ursolic acid derivatives. Eur J Med Chem. 40:582–589. 2005. View Article : Google Scholar : PubMed/NCBI
13	Shanmugam MK, Manu KA, Ong TH, Ramachandran L, Surana R, Bist P, Lim LH, Kumar AP, Hui KM and Sethi G: Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer. 129:1552–1563. 2011. View Article : Google Scholar : PubMed/NCBI
14	De Angel RE, Smith SM, Glickman RD, Perkins SN and Hursting SD: Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer. Nutr Cancer. 62:1074–1086. 2010. View Article : Google Scholar : PubMed/NCBI
15	Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, Deorukhkar A, Diagaradjane P, Wei C, Baladandayuthapani V, Krishnan S, et al: Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res. 18:4942–4953. 2012. View Article : Google Scholar : PubMed/NCBI
16	Yeh CT, Wu CH and Yen GC: Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol Nutr Food Res. 54:1285–1295. 2010. View Article : Google Scholar : PubMed/NCBI
17	Yu LB, Wang J, Ma BZ and Sun WZ: Inhibitive effect of ursolic acid on the invasion and metastasis of ovarian carcinoma cells HO-8910PM. Sichuan Da Xue Xue Bao Yi Xue Ban. 41:986–988. 2010.(In Chinese).
18	Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
19	Steller-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303. 1990. View Article : Google Scholar
20	Stetler-Stevenson WG, Liotta LA and Kleiner DE Jr: Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1434–1441. 1993.PubMed/NCBI
21	Chiarugi V, Magnelli L, Cinelli M and Basi G: Apoptosis and the cell cycle. Cell Mol Biol Res. 40:603–612. 1994.PubMed/NCBI
22	Fernald K and Kurokawa M: Evading apoptosis in cancer. Trends Cell Biol. 23:620–633. 2013. View Article : Google Scholar : PubMed/NCBI
23	Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 3:614–620. 1997. View Article : Google Scholar : PubMed/NCBI
24	Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
25	Blanc C, Deveraux QL, Krajewski S, Jänicke RU, Porter AG, Reed JC, Jaggi R and Marti A: Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res. 60:4386–4390. 2000.PubMed/NCBI
26	Seger R and Krebs EG: The MAPK signaling cascade. FASEB J. 9:726–735. 1995.PubMed/NCBI
27	Westwick JK, Bielawska AE, Dbaibo G, Hannun YA and Brenner DA: Ceramide activates the stress-activated protein kinases. J Biol Chem. 270:22689–22692. 1995. View Article : Google Scholar : PubMed/NCBI
28	Tibbles LA and Woodgett JR: The stress-activated protein kinase pathways. Cell Mol Life Sci. 55:1230–1254. 1999. View Article : Google Scholar : PubMed/NCBI
29	Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
30	Yu R, Shtil AA, Tan TH, Roninson IB and Kong AN: Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis. Cancer Lett. 107:73–81. 1996. View Article : Google Scholar : PubMed/NCBI
31	Chen YR, Meyer CF and Tan TH: Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem. 271:631–634. 1996. View Article : Google Scholar : PubMed/NCBI
32	Cagnol S and Chambard JC: ERK and cell death: mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence. FEBS J. 277:2–21. 2010. View Article : Google Scholar
33	Germain M, Affar EB, D’Amours D, Dixit VM, Salvesen GS and Poirier GG: Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem. 274:28379–28384. 1999. View Article : Google Scholar : PubMed/NCBI
34	Karikas GA: Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects. J BUON. 15:627–638. 2010.
35	Ou Y, Li Q, Wang J, Li K and Zhou S: Antitumor and apoptosis induction effects of paeonol on mice bearing EMT6 breast carcinoma. Biomol Ther (Seoul). 22:341–346. 2014. View Article : Google Scholar
36	Li Y, Lu X, Qi H, Li X, Xiao X and Gao J: Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and suppression of ERK1/2 MAPK in HeLa cells. J Pharmacol Sci. 125:202–210. 2014. View Article : Google Scholar : PubMed/NCBI
37	Kim KH, Seo HS, Choi HS, Choi I, Shin YC and Ko SG: Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Arch Pharm Res. 34:1363–1372. 2011. View Article : Google Scholar : PubMed/NCBI
38	Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 23:2838–2849. 2004. View Article : Google Scholar : PubMed/NCBI
39	Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ and Davis RJ: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 270:7420–7426. 1995. View Article : Google Scholar : PubMed/NCBI
40	Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K, Dent P and Fisher PB: Mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci USA. 99:10054–10059. 2002. View Article : Google Scholar : PubMed/NCBI
41	Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, Ambrosino C, Benito M and Nebreda AR: P38α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell. 15:922–933. 2004. View Article : Google Scholar :
42	Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T and Takigawa M: CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem. 268:6058–6065. 2001. View Article : Google Scholar : PubMed/NCBI
43	Park JM, Greten FR, Li ZW and Karin M: Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science. 297:2048–2051. 2002. View Article : Google Scholar : PubMed/NCBI
44	Gong YY, Liu YY, Yu S, Zhu XN, Cao XP and Xiao HP: Ursolic acid suppresses growth and adrenocorticotrophic hormone secretion in AtT20 cells as a potential agent targeting adrenocorticotrophic hormone-producing pituitary adenoma. Mol Med Rep. 9:2533–2539. 2014.PubMed/NCBI
45	Liu XS and Jiang J: Induction of apoptosis and regulation of the MAPK pathway by ursolic acid in human leukemia K562 cells. Planta Med. 73:1192–1194. 2007. View Article : Google Scholar : PubMed/NCBI
46	Zhang YX, Kong CZ, Wang HQ, Wang LH, Xu CL and Sun YH: Phosphorylation of Bcl-2 and activation of caspase-3 via the c-Jun N-terminal kinase pathway in ursolic acid-induced DU145 cells apoptosis. Biochimie. 91:1173–1179. 2009. View Article : Google Scholar : PubMed/NCBI
47	Lynch CC and Matrisian LM: Matrix metalloproteinases in tumor-host cell communication. Differentiation. 70:561–573. 2002. View Article : Google Scholar : PubMed/NCBI
48	Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement-membrane collagen. Nature. 284:67–68. 1980. View Article : Google Scholar : PubMed/NCBI
49	Lee YD, Cui MN, Yoon HH, Kim HY, Oh IH and Lee JH: Down-modulation of Bis reduces the invasive ability of glioma cells induced by TPA, through NF-κB mediated activation of MMP-9. BMB Rep. 47:262–267. 2014. View Article : Google Scholar :
50	Ham M and Moon A: Inflammatory and microenvironmental factors involved in breast cancer progression. Arch Pharm Res. 36:1419–1431. 2013. View Article : Google Scholar : PubMed/NCBI
51	Yong HY and Moon A: Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch Pharm Res. 30:75–81. 2007. View Article : Google Scholar : PubMed/NCBI
52	Tsuchiya A, Kikuchi Y, Ando Y, Yoshida T and Abe R: Lymph node metastases in gastric cancer invading the submucosal layer. Eur J Surg Oncol. 21:248–250. 1995. View Article : Google Scholar : PubMed/NCBI